Lymphomyosot (Hameln Pharma GmbH)


Welcome to the PulseAid listing for the Lymphomyosot drug offered from Hameln Pharma GmbH. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hameln Pharma GmbH
NON-PROPRIETARY NAME: GERANIUM ROBERTIANUM and RORIPPA NASTURTIUM-AQUATICUM and TRIBASIC CALCIUM PHOSPHATE and LEVOTHYROXINE and
SUBSTANCE NAME: GERANIUM ROBERTIANUM; RORIPPA NASTURTIUM-AQUATICUM; FERROUS IODIDE; JUGLANS REGIA FLOWERING TOP; MYOSOTIS ARVENSIS; SCROPHULARIA NODOSA; TEUCRIUM SCORODONIA FLOWERING TOP; VERONICA OFFICINALIS FLOWERI
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient]
ROUTE: INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00


Lymphomyosot HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLymphomyosot from Hameln Pharma GmbH
LABELER NAME: Hameln Pharma GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 12; 3; 3; 3; 3; 3; 4; 4; 4; 4; 5; 6; 6; 12; 12([hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_)
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52919-123_aea30801-f2e6-48e6-9724-21ad9201b441
PRODUCT NDC: 52919-123
APPLICATION NUMBER:

Other GERANIUM ROBERTIANUM; RORIPPA NASTURTIUM-AQUATICUM; FERROUS IODIDE; JUGLANS REGIA FLOWERING TOP; MYOSOTIS ARVENSIS; SCROPHULARIA NODOSA; TEUCRIUM SCORODONIA FLOWERING TOP; VERONICA OFFICINALIS FLOWERI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hameln Pharma GmbHLymphomyosot